NCT02004717View on ClinicalTrials.gov

Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Solid Tumors
Interventions
DRUG

DS-8895a

Trial Locations (2)

277-8577

National Cancer Center Hospital East, Kashiwa

565-0871

Osaka University Hospital, Suita

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY